E. Van Cutsem
- Oncology top 2%
- Colorectal Cancer Treatments and Studies 48
- Cancer Treatment and Pharmacology 17
- Pancreatic and Hepatic Oncology Research 9
- HER2/EGFR in Cancer Research 9
- Gastroenterology top 2%
- Geriatrics and Gerontology top 2%
-
- Gastric Cancer Management and Outcomes 29
- Lung Cancer Treatments and Mutations 16
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 7
-
- Genetic factors in colorectal cancer 13
- Co-authors
- Júlio OliveiraP. RougierJean‐Baptiste BachetThomas SeufferleinJavier SastreRiccardo A. AudisioBengt GlimeliusMatti Aapro
- Journals
- Annals of Oncology (30 papers)Journal of Clinical Oncology (16 papers)European Journal of Cancer (7 papers)
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
E. Van Cutsem
87 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 104
- Oncology 1.5k
- Gastroenterology 195
- Geriatrics and Gerontology 126
- Pulmonary and Respiratory Medicine 771
- Hepatology 124
Countries citing papers authored by E. Van Cutsem
This map shows the geographic impact of E. Van Cutsem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Van Cutsem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Van Cutsem more than expected).
Fields of papers citing papers by E. Van Cutsem
This network shows the impact of papers produced by E. Van Cutsem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Van Cutsem. The network helps show where E. Van Cutsem may publish in the future.
Co-authorship network
The 25 scholars most cited alongside E. Van Cutsem, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 3 | |
| 8 | 2022 | 21 | |
| 9 | 2022 | 4 | |
| 10 | 2022 | 0 | |
| 11 | 2019 | 2 | |
| 12 | 2016 | 4 | |
| 13 | 2016 | 1 | |
| 14 | 2015 | 29 | |
| 15 | Analysis of HER2 expression and gene amplification in adenocarcinoma of the stomach and the gastro-oesophageal junction: rationale for the Belgian way of working. | 2012 | 12 |
| 16 | 2012 | 281 | |
| 17 | 2010 | 1 | |
| 18 | 2009 | 154 | |
| 19 | 2008 | 134 | |
| 20 | HER2-positive advanced gastric cancer: similar HER2-positivity levels to breast cancer | 2007 | 25 |
About E. Van Cutsem
E. Van Cutsem is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Microbiology, Gastroenterology and Pathology and Forensic Medicine, having authored 91 papers that have together received 2.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (48 papers), Gastric Cancer Management and Outcomes (29 papers), Cancer Treatment and Pharmacology (17 papers), Lung Cancer Treatments and Mutations (16 papers), Genetic factors in colorectal cancer (13 papers), Pancreatic and Hepatic Oncology Research (9 papers), HER2/EGFR in Cancer Research (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). The work is most often cited by research in Oncology (1.5k citations), Gastroenterology (195 citations), Geriatrics and Gerontology (126 citations), Pulmonary and Respiratory Medicine (771 citations) and Hepatology (124 citations). E. Van Cutsem has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Júlio Oliveira, P. Rougier, Jean‐Baptiste Bachet, Thomas Seufferlein, Javier Sastre, Riccardo A. Audisio, Bengt Glimelius, Matti Aapro, Dik J. Kwekkeboom and Gianfranco Delle Fave. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, European Journal of Cancer, ESMO Open and Clinical Colorectal Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.